Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President/CEO

Chief Financial Officer

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, and human papillomavirus associated malignancies. The company is developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2022-12-02	Premium	acquired	Premium	Premium	Premium	President/CEO
2022-12-02	Premium	sold (taxes)	Premium	Premium	Premium	President/CEO
2021-12-13	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-12-13	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-06-16	Premium	bought	Premium	Premium	Premium	-
2021-06-16	Premium	acquired	Premium	Premium	Premium	-
2021-06-15	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-06-15	Premium	bought	Premium	Premium	Premium	-
2021-06-15	Premium	bought	Premium	Premium	Premium	-
2021-06-15	Premium	bought	Premium	Premium	Premium	-
2021-06-15	Premium	acquired	Premium	Premium	Premium	President/CEO
2021-06-15	Premium	sold (taxes)	Premium	Premium	Premium	President/CEO
2020-02-14	Premium	acquired	Premium	Premium	Premium	-
2020-02-14	Premium	acquired	Premium	Premium	Premium	-
2020-02-14	Premium	acquired	Premium	Premium	Premium	-
2020-02-14	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer

PDSB - PDS Biotechnology Corp Stock Price, Fair Value and News

Latest Insider Trading transactions for PDSB